Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

Overview
Karyotyping01:17

Karyotyping

Overview
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ADLM Guidance Document on Incorporating Gender Diversity in Pathology and Laboratory Medicine.

The journal of applied laboratory medicine·2026
Same author

Path to Health Equity and Improved Outcomes through Inclusive Sex and Gender Data Collection in Genomic Testing.

The Journal of molecular diagnostics : JMD·2025
Same author

Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.

Cancer genetics·2023
Same author

Dual role of lipids for genome stability and pluripotency facilitates full potency of mouse embryonic stem cells.

Protein & cell·2023
Same author

Words matter: The language of difference in human genetics.

Genetics in medicine : official journal of the American College of Medical Genetics·2022
Same author

Conventional and Spectral Karyotyping of Murine Cerebellar Granule Neuron Progenitors.

Methods in molecular biology (Clifton, N.J.)·2022

Related Experiment Video

Updated: May 27, 2026

Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Solid tumor cytogenetics: current perspectives.

Gouri Nanjangud1, Ina Amarillo, P Nagesh Rao

  • 1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, 2-226 Rehab Center, 1000 Veteran Avenue, Los Angeles, CA 90024, USA.

Clinics in Laboratory Medicine
|November 29, 2011
PubMed
Summary
This summary is machine-generated.

Conventional cytogenetics and Fluorescence In Situ Hybridization (FISH) are crucial for diagnosing and managing solid tumors. These cost-effective methods efficiently detect chromosomal aberrations, aiding in modern pathology practices.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Related Experiment Videos

Last Updated: May 27, 2026

Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Area of Science:

  • Oncology
  • Cytogenetics
  • Molecular Pathology

Background:

  • Conventional cytogenetics and Fluorescence In Situ Hybridization (FISH) are established techniques in solid tumor diagnostics.
  • These methods are vital for identifying clinically significant chromosomal aberrations.
  • Their cost-effectiveness and acceptable turnaround times make them valuable screening tools.

Purpose of the Study:

  • To review the significant role of chromosomal analysis and FISH in the clinical management of solid tumors.
  • To highlight key solid tumor types where these techniques are routinely applied.
  • To emphasize the diagnostic and prognostic value of cytogenetic analysis in oncology.

Main Methods:

  • Review of literature focusing on chromosomal analysis and FISH in solid tumor management.
  • Description of representative solid tumor cases where these techniques are applied.
  • Analysis of the diagnostic utility and clinical impact of detected chromosomal aberrations.

Main Results:

  • Cytogenetic analysis and FISH are integral to the diagnosis and management of various solid tumors.
  • These techniques effectively detect a wide range of clinically relevant chromosomal aberrations.
  • The methods provide rapid and cost-effective screening for genetic alterations in tumors.

Conclusions:

  • Chromosomal analysis and FISH remain indispensable tools in the routine clinical management of solid tumors.
  • Their ability to detect chromosomal aberrations supports accurate diagnosis and treatment decisions.
  • These cytogenetic techniques are essential for advancing personalized oncology.